63
Growth Score
pts
Heat Score
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
962416
Attillaps Pharmaceuticals develops drugs for inflammatory conditions, focusing on ophthalmology and skin microbiome.
- Frank Spallitta: Founder and CEO
About the Company
Attillaps Pharmaceuticals is a developmental-stage company focused on pioneering small-molecule drug platforms targeting inflammatory skin and ophthalmic conditions. The company’s indications include rosacea and blepharitis, with additional interests in meibomian gland dysfunction, atopic dermatitis, acne vulgaris, ocular rosacea, and hidradenitis
suppurativa.
